Abstract
Unrealistic therapeutic beliefs are very common—the majority of patient-subjects (up to 94%) enrol in phase 1 trials seeking and expecting significant medical benefit, even though the likelihood of such benefit...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have